Huachansu injection enhances anti-colorectal cancer efficacy of irinotecan and alleviates its induced intestinal toxicity through upregulating UGT1A1-OATP1B3 expression in vitro and in vivo
Journal of Integrative Medicine · 2025
DOI: 10.1016/j.joim.2025.06.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Integrative Medicine, 2025. Verfasst von Bo Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Changning Mental Health Center, East China Normal University, Shanghai 200335, China; Department of Pharmacy, Shanghai Sixth People's Hospit…. Hauptthemen laut MEDLINE: Irinotecan, Glucuronosyltransferase, Colorectal Neoplasms, Drugs, Chinese Herbal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Pudong Commission of Science and Technology and Economy and informatization, Pudong New Area Health Commission Health Research Project, Shanghai Pudong New Area Health Commission.
Abstract (Originalsprache)
OBJECTIVE: Huachansu injection (HCSI), a promising anti-cancer Chinese medicine injection, has been reported to have the potential for reducing the toxicity of chemotherapy and improving the quality of life for colorectal cancer (CRC) patients. The objective of this study is to explore the synergistic and detoxifying effects of HCSI when used in combination with irinotecan (CPT-11). METHODS: To investigate the effect of HCSI on anti-CRC efficacy and intestinal toxicity of CPT-11, we measured changes in the biological behavior of LoVo cells in vitro, and anti-tumor effects in LoVo cell xenograft nude mice models in vivo. Meanwhile, the effect of HCSI on intestinal toxicity and the uridine diphosphate-glucuronosyltransferase 1A1 (UGT1A1) expression was investigated in the CPT-11-induced colitis mouse model. Subsequently, we measured the effect of HCSI and its 13 constituent bufadienolides on the expression of UGT1A1 and organic anion transporting polypeptides 1B3 (OATP1B3) in HepG2 cells. RESULTS: The combination index (CI) results showed that the combination of HCSI and CPT-11 exhibited a synergistic effect (CI < 1), which significantly suppressing the LoVo cell migration, enhancing G2/M and S phase arrest, and inhibiting tumor growth in vivo. Additionally, the damage to intestinal tissues was attenuated by HCSI in CPT-11-induced colitis model, while the increased expression of UGT1A1 in HepG2 cells and in mouse was observed. CONCLUSION: The co-therapy with HCSI alleviated the intestinal toxicity induced by CPT-11 and exerted an enhanced anti-CRC effect. The detoxifying mechanism may be related to the increased expression of UGT1A1 and OATP1B3 by HCSI and its bufadienolides components. The findings of this study may serve as a theoretical insights and strategies to improve CRC patient outcomes. Please cite this article as: Jiang B, Meng ZY, Hu YJ, Chen JJ, Zong L, Xu LY, Zhang XQ, Zhang JX, Han YL. Huachansu injection enhances anti-colorectal cancer efficacy of irinotecan and alleviates its induced intestinal toxicity through upregulating UGT1A1-OATP1B3 expression in vitro and in vivo. J Integr Med. 2025; 23(5):576-590.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Changning Mental Health Center, East China Normal University, Shanghai 200335, China; Department of Pharmacy, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Sha…
- Department of Pharmacy, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China; College of Food Science and Technology, Shanghai Ocean University, Shangha…
- Department of Pharmacy, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.
Förderung
- Pudong Commission of Science and Technology and Economy and informatization
- Pudong New Area Health Commission Health Research Project
- Shanghai Pudong New Area Health Commission
- Shanghai Municipal Health Commission
- Traditional Chinese Medicine Inheritance and Scientific and Technological Innovation Project of Shanghai Municipal Health Commission
Zitieren
APA
Jiang, B., Meng, Z. Y., Hu, Y. J., Chen, J. J., Zong, L., Xu, L. Y., Zhang, X. Q., Zhang, J. X., & Han, Y. L. (2025). Huachansu injection enhances anti-colorectal cancer efficacy of irinotecan and alleviates its induced intestinal toxicity through upregulating UGT1A1-OATP1B3 expression in vitro and in vivo. Journal of Integrative Medicine. https://doi.org/10.1016/j.joim.2025.06.006
Vancouver
Jiang B, Meng ZY, Hu YJ, Chen JJ, Zong L, Xu LY, et al. Huachansu injection enhances anti-colorectal cancer efficacy of irinotecan and alleviates its induced intestinal toxicity through upregulating UGT1A1-OATP1B3 expression in vitro and in vivo. Journal of Integrative Medicine. 2025. doi:10.1016/j.joim.2025.06.006
BibTeX
@article{Jiang2025,
author = {Jiang, Bo and Meng, Zhao-Yang and Hu, Yu-Jie and Chen, Jun-Jun and Zong, Ling and Xu, Ling-Yan and Zhang, Xiang-Qi and Zhang, Jing-Xian and Han, Yong-Long},
title = {Huachansu injection enhances anti-colorectal cancer efficacy of irinotecan and alleviates its induced intestinal toxicity through upregulating UGT1A1-OATP1B3 expression in vitro and in vivo},
journal = {Journal of Integrative Medicine},
year = {2025},
doi = {10.1016/j.joim.2025.06.006}
}
EUVIMED